Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

The scRNA-seq analysis of immune cells in colorectal cancer liver metastatic lesions formed by MC38-LM3b-shScramble and MC38-LM3b-shSLAMF3.

ABSTRACT: The scRNA-seq analysis of immune cells in colorectal cancer liver metastatic lesions formed by MC38-LM3b-shScramble and MC38-LM3b-shSLAMF3.

PROVIDER: PRJNA1226251 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

The scRNA-seq analysis of immune cells in colorectal cancer liver metastatic lesions formed by MC38-LM3b-shScramble and MC38-LM3b-shSLAMF3.

Project description:MC38-LM3b-shScramble and MC38-LM3b-shSLAMF3 liver metastatic lesions formed by spleen injection were used to isolate immune cells with CD45 magnetic beads, followed by scRNA-seq sequencing to analyze the effect of SLAMF3 on the colorectal cancer liver metastatic microenvironment.

2025-09-10 | GSE290135 | GEO

RNA Sequencing Identification of MC38-P and Its Liver Metastatic Derivatives, MC38-LM3a and MC38-LM3b [Bulk RNA-seq]

Project description:Mouse-derived MC38 cells were subjected to in vivo selection to obtain colorectal cancer liver metastatic derivatives, MC38-LM3a and MC38-LM3b. Subsequently, their gene expression characteristics were identified through transcriptomic sequencing.

2025-09-10 | GSE290134 | GEO

Proteomics analysis of the matrisome from MC38 experimental mouse liver metastases

Project description:Dissemination of primary tumors to distant anatomical sites has a substantial negative impact on patient prognosis. The liver is a common site for metastases from colorectal cancer, and patients with hepatic metastases have generally much shorter survival, raising a need to develop and implement novel strategies for targeting metastatic disease. The extracellular matrix (ECM) is a meshwork of highly crosslinked, insoluble, high molecular weight proteins maintaining tissue integrity and establishing cell-cell interactions. Emerging evidence identifies the importance of the ECM in cancer cell migration, invasion, intravasation, and metastasis. Here, we isolated the extracellular matrix from MC38 mouse liver metastases using our optimized method of mild detergent solubilization followed by biochemical enrichment. The matrices were subjected to label-free quantitative mass spectrometry analysis, revealing proteins highly abundant in the metastatic matrisome. The resulting list of differentially expressed proteins significantly predicted survival in patients with colorectal cancer but not other cancers with strong involvement of the extracellular matrix component. One of the proteins upregulated in liver metastatic ECM, Annexin A1, was not previously studied in the context of cancer-associated matrisome. Here we show that Annexin A1 was markedly upregulated in colon cancer cell lines compared to cancer cells of other origin, and also overrepresented in human primary colorectal lesions as well as hepatic metastases in comparison with their adjacent healthy tissue counterparts. In conclusion, our study provides a comprehensive ECM characterization of MC38 experimental liver metastases and proposes Annexin A1 as a putative target for this disease.

2020-05-26 | PXD013350 | Pride

Expression profile of primary and wound metastatic lesions of melanoma

Project description:The phenomenon that metastatic lesion developed on injured sites has long been recognized in a number of cancers, such as melanoma. The factors associated with wound healing that attract circulating tumor cells have remained unknown, however. A patient with acral lentiginous melanoma presented with a metastatic lesion that appeared 1 month after trauma. To explore the molecular mechanism underlying the promotion of wound metastasis in melanoma, we performed microarray analysis of the metastatic lesions (n = 2) and the primary lesions (n = 3) of the patient. Using Human Genome U133 Plus 2.0 array, we compared global gene expression profiles of tissues derived from the patient’s primary (n = 3) and wound metastatic (n = 2) lesions to search for particular biological functions in genes of which expression intensities were increased in the wound metastasic lesions of melanoma.

2015-06-26 | E-GEOD-62837 | biostudies-arrayexpress

RNA Sequencing Identification of MC38-P and Its Liver Metastatic Derivatives, MC38-LM3a and MC38-LM3b [Bulk RNA-seq]

Project description:RNA Sequencing Identification of MC38-P and Its Liver Metastatic Derivatives, MC38-LM3a and MC38-LM3b [Bulk RNA-seq]

| PRJNA1226250 | ENA

Expression profile of primary and wound metastatic lesions of melanoma

2015-06-26 | GSE62837 | GEO

Immunopeptidome on MC38 Cell line

Project description:PTM – driven antigenicity – immunopeptidome of MC38 cell line

2022-10-12 | PXD017448 | Pride

RNA-seq of parental MC38 and anti-PD-1 resistant MC38 subcutaneous tumors

Project description:MC38 tumors resistant to anti-PD-1 treatment (MC38-resistant) were generated through serial in vivo passaging, and global gene expression analysis was used to compare resistant and parental tumors. MC38 and MC38-resistant tumors exhibited widespread changes in global gene expression.

2021-07-22 | GSE180309 | GEO

Biomarkers of colorectal precancerous lesions

Project description:Biomarkers of colorectal precancerous lesions

| PRJNA970834 | ENA

Next generation sequencing of a unique set of glycovariant MC38 mouse colorectal cancer cell lines generated with CRISPR-Cas9 and CRISPR-dCas-VPR technology

Project description:To investigate the effect of different tumor-associated glycans, mouse colorectal cancer cells (MC38 cell line) were genetically modified using CRISPR-Cas9 and CRISPR-dCas-VPR technology targeting different genes involved in glycosylation pathways. To study the effect of altered glycosylation at the transcriptional level, next generation sequencing was performed on the entire panel of glycovariant MC38 cell lines. The MC38 knockout cell lines created with the CRISPR-Cas9 technology are: MC38-MOCK#1, MC38-CMAS KO, MC38-COSMC KO, MC38-CMAS+COSMC KO. The MC38 overexpressing cell lines generated with the CRISPR-dCas9-VPR technology are: MC38-MOCK#2, MC38-FUT4, MC38-FUT9. Details on the cell lines can be found in the corresponding manuscript(s).

2020-08-05 | GSE143700 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data